| |
|
|
|
Clearside Biomedical Inc.  
|
|
1.54 0.06 (0.04%) |
09-30 16:00 |
|
Open: |
1.48 |
Pre close: |
1.48 |
Target:
|
1.97
|
|
High: |
1.54 |
Low: |
1.4671 |
Resistance:
|
1.68
1.84
|
|
Volume: |
129,640 |
Market Cap: |
71M |
Support:
|
1.43
1.19
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.50
 |
MACD |
MACD(12,26):
|
-0.06 |
|
MA(20): |
1.61 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
1.82 |
Stochastic Oscillator |
%K(14,3):
|
19.51  |
|
MA(250): |
1.89 |
%D(3): |
17.80 |
|
Average Volume(K) |
3-Month: |
28548
|
52-Week |
High:
|
4.13 |
|
10-Days: |
12473 |
Low: |
0.65 |
|
RSI |
RSI(14):
|
38.47 |
Change(%): |
126.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.428 |
Return on Equity (ttm) |
-181.3 |
Shares Out. (M) |
46.34 |
|
EPS Est. Current Year |
-2.100 |
Return on Assets (ttm) |
-39.8 |
Shares Float (M) |
30.82 |
|
EPS Est. Next Year |
-2.190 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.36 |
|
EPS Est. Next Quarter |
-0.590 |
Qtrly Rev. Growth |
686.7 |
% Held by Institutions |
35.21 |
|
Forward EPS |
-0.810 |
Gross Profit (p.s.) |
0.047 |
Shares Short (K) |
1620 |
|
Book Value (p.s.) |
0.160 |
EBITDA (p.s.) |
-0.323 |
P/E |
-3.43 |
|
Sales Per Share |
0.141 |
Qtrly Earnings Growth |
0.00 |
P/BV |
9.19 |
|
Profit Margin |
-280.03 |
Operating Cash Flow
(M) |
-10.38 |
P/S |
10.43 |
|
Operating Margin |
-232.23 |
Levered Free Cash Flow
(M) |
-2.13 |
P/CF |
-6.56 |
|
|
|
|
|
|
